New combo therapy shows promise for tough liver cancer cases

This study tested a new treatment for advanced liver cancer that has spread into the major blood vessels of the liver. Thirty patients received a special type of radiation along with an immunotherapy drug called tislelizumab. The goal was to see if this combination could help patients live longer and shrink their tumors. Patients continued on maintenance therapy until their disease got worse or side effects became too much.